Cytotoxic Effect of Teranecrone and Doxorubicin on Human Colorectal Adenocarcinoma (CaCo-2) Cell Line
Ege Tıp Bilimleri Dergisi · 2022
DOI: 10.33713/egetbd.1192800 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ege Tıp Bilimleri Dergisi, 2022. Verfasst von Numan TAŞPINAR und 1 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
OBJECTİVE: In this study, it was aimed to evaluate the antineoplastic efficacy of Teranecron, which is frequently used in veterinary medicine, on human colorectal adenocarcinoma. MATERİALS AND METHODS: Teranecron (TRN) was used to evaluate its effectiveness in the study, and the antineoplastic drug Doxorubicin was used as a positive control. The cytotoxic activity of Teranecron on the human colorectal cell line CaCo-2 was investigated. MTT proliferation test was used to determine the viability rates. ANOVA Tukey test was used for statistical analysis and the level of significance was accepted as P
Zitieren
APA
TAŞPINAR, N., & ERTUĞRUL, M. S. (2022). Cytotoxic Effect of Teranecrone and Doxorubicin on Human Colorectal Adenocarcinoma (CaCo-2) Cell Line. Ege Tıp Bilimleri Dergisi. https://doi.org/10.33713/egetbd.1192800
Vancouver
TAŞPINAR N, ERTUĞRUL MS. Cytotoxic Effect of Teranecrone and Doxorubicin on Human Colorectal Adenocarcinoma (CaCo-2) Cell Line. Ege Tıp Bilimleri Dergisi. 2022. doi:10.33713/egetbd.1192800
BibTeX
@article{TAPINAR2022,
author = {TAŞPINAR, Numan and ERTUĞRUL, Muhammed Sait},
title = {Cytotoxic Effect of Teranecrone and Doxorubicin on Human Colorectal Adenocarcinoma (CaCo-2) Cell Line},
journal = {Ege Tıp Bilimleri Dergisi},
year = {2022},
doi = {10.33713/egetbd.1192800}
}
EUVIMED